Federal health officials are giving a small biotech company nearly  million to speed up development of another vaccine against Ebola the third in a pipeline of vaccines to fight the virus Baltimorebased Profectus BioSciences Inc has been working on the vaccine made using another virus called vesicular stomatitis virus The virus is genetically engineered to carry a piece of the Ebola virus to help stimulate the immune system The company will manufacture vaccine for use in animal safety studies and future clinical trials and conduct animal studies to test safety The contract can be extended to a total of  months and  million an office within the Health and Human Services Department   The National Institutes of Health is helping with Phase  clinical trials  meant to show a vaccine is safe  for an Ebola vaccine developed by GlaxoSmithKline and one developed by the Public Health Agency of Canada and licensed to NewLink Genetics Corp Itll be months before any vaccine would be available and even then it will be a small amount probably used to protect health care workers But experts say its a vital first step to getting doctors nurses and technicians to   in West Africa Health workers are among those   of getting infected